Outset Medical (OM) Non Operating Interest Expenses (2019 - 2026)

Outset Medical (OM) has reported Non Operating Interest Expenses for 8 consecutive years, with $3.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 0.95% year-over-year to $3.4 million in Q2 2026; TTM through Jun 2026 was $13.7 million, a 27.47% decrease from a year earlier, with the FY2025 full-year figure at $14.0 million, down 41.55% from the prior year.
• Non Operating Interest Expenses was $3.4 million for Q2 2026 at Outset Medical, up from $3.4 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $6.1 million in Q3 2024 and troughed at $422000.0 in Q1 2022.
• A 5-year average of $3.4 million and a median of $3.4 million in 2023 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses surged 597.16% in 2023 and tumbled 42.72% in 2025, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $2.1 million in 2022, then soared by 63.02% to $3.4 million in 2023, then jumped by 70.47% to $5.8 million in 2024, then slumped by 40.93% to $3.4 million in 2025, then grew by 0.03% to $3.4 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $3.4 million (Q2 2026), $3.4 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.